Allogeneic Hematopoietic Stem Cell Transplantation Recipient

12 clinical trials · Condition

Record	Firm	Date
Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (NCT03851081)	Roswell Park Cancer Institute	2021-01-21
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT (NCT03665675)	Sumithira Vasu	2020-11-07
High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant (NCT03719092)	Ohio State University Comprehensive Cancer Center	2020-02-07
Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant (NCT03925532)	Roswell Park Cancer Institute	2019-12-19
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant (NCT03779854)	Fred Hutchinson Cancer Center	2019-08-29
Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT03600155)	M.D. Anderson Cancer Center	2018-10-11
Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant (NCT02083250)	M.D. Anderson Cancer Center	2014-03-06
Allogeneic Stem Cell Transplant for CLL (NCT01629511)	M.D. Anderson Cancer Center	2012-11-21

Every clearance here is in the API, with alerts when new ones post.